Evidence map›Paper›PMID 24121502›Full record

ArticleThe Journal of biological chemistry2013

Involvement of reactive oxygen species in a feed-forward mechanism of Na/K-ATPase-mediated signaling transduction.

Yanling Yan, Anna P Shapiro, Steven Haller, Vinai Katragadda, Lijun Liu, Jiang Tian, Venkatesha Basrur, Deepak Malhotra, Zi-Jian Xie, Nader G Abraham and 2 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 76 papers.

0numbers the graph read from it
0cells of the map it votes in
76citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

76 citing papers in PubMed, 97 citations in OpenAlex.

  1. Trial
  2. Na/K-ATPase Signaling in Adipocytes Promotes Atherosclerosis.Arteriosclerosis, thrombosis, and vascular biology · 2026
    Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. pNaKtide Inhibits Na/K-ATPase Signaling and Attenuates Obesity.Journal of clinical and medical sciences · 2023
    Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

16 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Yanling YanDepartment of Pharmacology, Physiology and Toxicology, JCE School of Medicine at Marshall University, Huntington, West Virginia 25755; Institute of Biomedical Engineering, Yanshan University, Qinhuangdao 066004, China.
Anna P ShapiroDepartment of Medicine, University of Toledo College of Medicine, Toledo, Ohio 43614.
Steven HallerDepartment of Medicine, University of Toledo College of Medicine, Toledo, Ohio 43614.
Vinai KatragaddaDepartment of Medicine, University of Toledo College of Medicine, Toledo, Ohio 43614.
Lijun LiuDepartment of Pharmacology, University of Toledo College of Medicine, Toledo, Ohio 43614.
Jiang TianDepartment of Medicine, University of Toledo College of Medicine, Toledo, Ohio 43614; Department of Pharmacology, University of Toledo College of Medicine, Toledo, Ohio 43614.
Venkatesha BasrurDepartment of Pathology, University of Michigan, Ann Arbor, Michigan 48109.
Deepak MalhotraDepartment of Medicine, University of Toledo College of Medicine, Toledo, Ohio 43614.
Zi-Jian XieDepartment of Medicine, University of Toledo College of Medicine, Toledo, Ohio 43614; Department of Pharmacology, University of Toledo College of Medicine, Toledo, Ohio 43614.
Nader G AbrahamDepartment of Pharmacology, Physiology and Toxicology, JCE School of Medicine at Marshall University, Huntington, West Virginia 25755.
Joseph I ShapiroDepartment of Pharmacology, Physiology and Toxicology, JCE School of Medicine at Marshall University, Huntington, West Virginia 25755; Department of Medicine, University of Toledo College of Medicine, Toledo, Ohio 43614.
Jiang LiuDepartment of Pharmacology, Physiology and Toxicology, JCE School of Medicine at Marshall University, Huntington, West Virginia 25755. Electronic address: liuj@marshall.edu.
University of Toledo · USMarshall University · USUniversity of Michigan–Ann Arbor · US

Funding

Vasoregulatory Function of CYP2E1-Derived EicosanoidsP01HL034300 · NHLBI · NEW YORK MEDICAL COLLEGE · PI JIANG, HOULI · 1985 to 2015
$33.4M
Receptor Na/K-ATPase Antagonists As Novel Therapeutics For Renal/Cardiac DiseasesR01HL109015 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI SHAPIRO, JOSEPH ISAAC, XIE, ZIJIAN · 2011 to 2014
$2.2M
Na/K-ATPase Reduction in Renal Disease-Related Cardiac DysfunctionR01HL105649 · NHLBI · UNIVERSITY OF TOLEDO HEALTH SCI CAMPUS · PI TIAN, JIANG · 2012 to 2016
$1.8M
NHLBI NIH HHS P01 HL034300NHLBI NIH HHS R01 HL-105649NHLBI NIH HHS R01 HL105649NHLBI NIH HHS R01 HL-109015NHLBI NIH HHS R01 HL109015
6 · The paper itself

Abstract

Cardiotonic steroids (such as ouabain) signaling through Na/K-ATPase regulate sodium reabsorption in the renal proximal tubule. We report here that reactive oxygen species are required to initiate ouabain-stimulated Na/K-ATPase·c-Src signaling. Pretreatment with the antioxidant N-acetyl-L-cysteine prevented ouabain-stimulated Na/K-ATPase·c-Src signaling, protein carbonylation, redistribution of Na/K-ATPase and sodium/proton exchanger isoform 3, and inhibition of active transepithelial (22)Na(+) transport. Disruption of the Na/K-ATPase·c-Src signaling complex attenuated ouabain-stimulated protein carbonylation. Ouabain-stimulated protein carbonylation is reversed after removal of ouabain, and this reversibility is largely independent of de novo protein synthesis and degradation by either the lysosome or the proteasome pathways. Furthermore, ouabain stimulated direct carbonylation of two amino acid residues in the actuator domain of the Na/K-ATPase α1 subunit. Taken together, the data indicate that carbonylation modification of the Na/K-ATPase α1 subunit is involved in a feed-forward mechanism of regulation of ouabain-mediated renal proximal tubule Na/K-ATPase signal transduction and subsequent sodium transport.

Indexed as

AcetylcysteineAnimalsCell LineCSK Tyrosine-Protein KinaseEnzyme InhibitorsFree Radical ScavengersMultienzyme ComplexesOuabainProtein CarbonylationProteolysisReactive Oxygen SpeciesSignal TransductionSodium-Potassium-Exchanging ATPasesrc-Family KinasesSwineAcetylcysteineCSK Tyrosine-Protein KinaseEnzyme InhibitorsFree Radical ScavengersMultienzyme ComplexesOuabainReactive Oxygen SpeciesSodium-Potassium-Exchanging ATPasesrc-Family KinasesHypertensionNAK-ATPaseNa/K-ATPase SignalingReactive Oxygen Species (ROS)Signal TransductionSodium Transport

Identifiers

PMID24121502
PMCPMC3837165
OpenAlexW2014221097

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.